Sally Blount

Track

Insider profile

Currently holds positions in Abbott Laboratories and Ulta Beauty Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 25% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Abbott Laboratories Dec. 9, 2011 -
Independent Director Ulta Beauty Inc Dec. 6, 2017 -
Sally Blount's trades of Abbott Laboratories's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
448.60
Quantity 13,810 -11.9%
Value US$1,821,236
Transaction date
Proposed sale
Price
337.63
Quantity 80,845
Value US$4,524,058
Transaction date
Sale
Price
411.91
Quantity 42,415 +4.3%
Value US$1,661,026
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-02 2025-04-30
S Sale
13,810 -11.9%
448.60
US$1,821,236 		13,810 -11.9% 448.60 US$1,821,236
2025-04-30 2025-04-30
PrS Proposed sale
80,845
337.63
US$4,524,058 		80,845 337.63 US$4,524,058
2019-06-24 2019-06-21
S Sale
42,415 +4.3%
411.91
US$1,661,026 		42,415 +4.3% 411.91 US$1,661,026